Why lozenges?

Children are the category of patients who are very difficult to get to take the necessary medications in case of illness. Children pay very close attention to both the smell and taste of drugs. The child’s acceptance of the drug has become a key factor in pediatrics for compliance with the treatment regimen and, therefore, safety and effectiveness.

Almost all children love lozenges and candies because of their sweet taste and pleasant smell. Therefore, when developing the JUVENTIS series, we took into account the taste and smell factor first and foremost. Therefore, all JUVENTIS supplements are produced in the form of tasty and aromatic tablets that the child will take with pleasure.

Efficiency of sublingual intake

The active ingredients of JUVENTIS supplements are absorbed into the blood sublingually, that is, under the tongue.

The main advantages of sublingual administration are:

• faster onset of action of active ingredients due to direct absorption into the bloodstream through the mucous membranes under the tongue
• this route also bypasses the digestive system, which provides higher bioavailability of ingredients compared to conventional oral administration
• sublingual administration may be more convenient for patients who have difficulty swallowing tablets or capsules

About nanotechnology

All JUVENTIS supplements contain nano-ingredients. The small size and large surface area of nanomaterials allow them to easily penetrate cells and interact with biomolecules. Nanomaterials have better absorption, bioavailability and stability. In addition, nanotechnology can also improve the targeted delivery of active ingredients, allowing more precise action on specific cells or tissues of the body. This can lead to a reduction in side effects and an increase in the overall effectiveness of treatment.

Manufacturing standards

JUVENTIS supplements are registered with the FDA and are manufactured according to the GMP standard. GMP, which stands for “good manufacturing practices,” is the part of quality assurance that guarantees pharmaceuticals are regularly manufactured and controlled to the quality standards appropriate for their intended use and as stipulated by the product specification. It is also known as “cGMP” or “current good manufacturing practice.”

GMP specifies general measures to guarantee that processes required for production and testing are precisely defined, validated, reviewed, and documented, and that the people, facilities, and materials are appropriate for the production of pharmaceuticals and biologicals, including vaccines. It also defines quality measures for both production and quality control.